DNase-seq adapts traditional DNase I footprinting 1 and leverages modern DNA sequencing to identify regions of the genome where regulatory factors interact with DNA to modify chromatin structure and ...
Coronaviruses are a group of RNA viruses that cause diseases in mammals and birds. In humans and birds, they cause respiratory tract infections that can range from mild to lethal. Mild illnesses in ...
New research has developed an immunotherapy for cancer by combining DNase I with CAR T-cell therapy. The research conducted by Xenetic Biosciences titled, "The synergistic action of DNase I and CAR T ...
More than 30% of patients with pleural infection either die or require surgery. Drainage of infected fluid is key to successful treatment, but intrapleural fibrinolytic therapy did not improve ...
Participants in a phase I/II clinical trial of a new enzyme-based treatment for severe dry eye disease experienced reduced signs of disease and discomfort, according to a paper in Translational Vision ...
To the Editor: Rahman and colleagues (Aug. 11 issue) 1 found improved fluid drainage in patients with pleural infections and a reduced frequency of surgical referral and duration of hospital stay ...
FRAMINGHAM, MA / ACCESS Newswire / November 19, 2025 / Xenetic Biosciences, Inc. (NASDAQ:XBIO) (“Xenetic” or the “Company”), a biopharmaceutical company focused on advancing innovative immuno-oncology ...
FRAMINGHAM, MA - Xenetic Biosciences, Inc. (NASDAQ:XBIO), a micro-cap biotech company with a market capitalization of $5.5 million, announced Wednesday it has extended its research collaboration with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback